Avalyn Pharma Inc. Common Stock
NASDAQ:AVLNMedical - Pharmaceuticals
+$0.52 today
- Market cap
- $1.23B
- Beta
- 0.00
Volume 0.40M
Average 0.51M
AVLN Sales of Investments
Cash received from selling or redeeming investments.
Sales of Investments history
Currency unavailable · from the cash flow
No Sales of Investments data reported for this period type.
Sales of Investments vs competitors
How AVLN compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $1.58B USD | -19.0% | +203.2% | 138.4% | |
VCREVicore Pharma Holding AB | LTM Jun 2026 | SEK 370.44M SEK | +259.5% | +70.8% | 27853.1% |
| LTM Mar 2026 | $195.82M USD | -11.7% | — | 54.3% | |
| LTM Mar 2026 | $14.31M USD | +27.9% | — | 12.2% | |
AVLNAvalyn Pharma Inc. Common Stock | — | — | — | — | — |
| Peer median (excluding AVLN) | — | +8.1% | +137.0% | 96.4% | |
Competitors are the stored peer set for AVLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Avalyn Pharma Inc. Common Stock
NASDAQ:AVLN
Intrinsic Alpha fair value
Locked
Current Price
$27.69
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.